ACM
AMGN icon

Arlington Capital Management’s Amgen AMGN Stock Holding History

Arlington Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-20,665
Closed -$3.2M – 14
2015
Q2 		$3.2M Buy
20,665
+1,876
+10% +$301K 2.15% 14
2015
Q1 		$3M Buy
18,789
+1,852
+11% +$292K 2.15% 14
2014
Q4 		$2.7M Buy
+16,937
New +$2.64M 2.28% 13

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Arlington Capital Management's AMGN Position: Q3 2015 in Review

Arlington Capital Management sold out of Amgen (AMGN) in Q3 2015, closing a stake of 20,665 shares — an estimated $3.2M sold.

Arlington Capital Management first reported a position in AMGN in Q4 2014 and held it in 3 quarters. The position peaked at $3.2M in Q2 2015. 1,380 funds tracked by Wall St. Rank hold AMGN as of Q3 2015.

  • Arlington Capital Management reported no remaining Amgen position as of Q3 2015 after selling out during the quarter.
  • Arlington Capital Management sold 20,665 Amgen shares in Q3 2015, an estimated $3.2M.
  • Arlington Capital Management first reported a position in Amgen in Q4 2014 and held it in 3 quarters.
  • Arlington Capital Management's Amgen position peaked at $3.2M in Q2 2015.
  • 1,380 funds tracked by Wall St. Rank held Amgen as of Q3 2015.

Based on Arlington Capital Management's 13F filing for Q3 2015, filed 12 Nov 2015.